Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
3 insiders in a week, 2nd time since 2021Traded Mar 27 · filed 3 days later
Since the trade −54.5% · S&P 500 +16.7% · to Nov 16
The CEO of Lenz Therapeutics paid $251K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month. Shares held went up 57% with this purchase.
3 insiders in a week, 2nd time since 2021Traded Mar 27 · filed 3 days later
Since the trade −54.5% · S&P 500 +16.7% · to Nov 16
The CFO of Lenz Therapeutics paid $64K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month. Shares held went up 139% with this purchase.
3 insiders in a week, 2nd time since 2021Traded Mar 27 · filed 3 days later
Since the trade −54.5% · S&P 500 +16.7% · to Nov 16
A Lenz Therapeutics director paid $50K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month.
Since the trade −53.8% · S&P 500 +12.7% · to Nov 16
An Access Newswire director paid $11K out of pocket for Access Newswire shares. 1 other person at Access Newswire bought some too, in the same month. Shares held went up 26% with this purchase.